KUALA LUMPUR, Sept 8 (Bernama) -- Bursa Malaysia closed almost flat on Tuesday as buying interest rotated away from index heavyweights towards smaller-cap construction stocks, with sentiment affected by geopolitical uncertainty, said an analyst. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) eased 0.39 of a point to 1,714.40 from Monday’s close of 1,714.79. The benchmark index opened 1.65 points lower at 1,713.14 and moved between 1,710.44 and 1,714.50 throughout the trading session. The broader market was almost evenly balanced, with decliners leading gainers 548 to 546, while 598 counters were unchanged, 1,107 were untraded and 25 were suspended. Turnover expanded to 4.13 billion units valued at RM3.14 billion from 3.60 billion units valued at RM2.45 billion on Monday.
Why Analysts Like Pfizer: Pfizer is profitable and undervalued , offering solid income through dividends and room for price growth. The stock recently broke out of a bullish price pattern , showing momentum for further gains. Technical indicators suggest an uptrend is in place , with the short-term average price staying above the longer-term average. Financial Outlook: Pfizer’s expected performance over the next 3 years: Year Revenue Net Profit 2025 ~$62.5 billion ~$17.2 billion 2026 ~$62.4 billion ~$17.8 billion 2027 ~$61.2 billion ~$17.8 billion Net profit margin expected to stay strong at around 28.4% . Net profit growth over the next 3 years is forecasted at over 30% . What the Charts Are Saying: Pfizer’s price recently broke above a short-term resistance level. Strong buying momentum is confirmed by consistent higher lows and a bullish candlestick pattern (white Marubozu). Near-term price targets: Resistance: $...